Diabetes and its chronic complications in the she ethnic minority group of China

Diabetes Technology and Therapeutics

Volumn 14, Issue 5, 2012, Pages 430-439

  Lin, Yinghua ^a   Xu, Yuan ^a   Chen, Gang ^a   Lai, Xiaolan ^a   Huang, Baoying ^a   Chen, Zichun ^a   Yao, Longteng ^a   Zhu, Shaoheng ^a   Yao, Jin ^a   Wen, Junping ^a   Huang, Huibin ^a   Lin, Caijing ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR RISK; CHINA; CHINESE; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; ETHNICITY; FAMILY HISTORY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERURICEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; POPULATION RISK; POSTPRANDIAL STATE; PRIORITY JOURNAL; PULSE WAVE; RISK ASSESSMENT; SELF REPORT; SEX DIFFERENCE; SEX RATIO; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

BLOOD GLUCOSE; BODY MASS INDEX; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREDIABETIC STATE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION;

EID: 84860551852     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0244     Document Type: Article

References (31)

1. Wild S, Sicree R, Roglic G, King H, Green A: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
2. Yang WY, Lu JM, Weng JP, Jia WP, Ji LN, Xiao JZ, Shan ZY, Liu J, Tian HM, Ji QH, Zhu DL, Ge JP, Lin LX, Chen L, Guo XH, Zhao ZG, Li Q, Zhou ZG, Shan GL, He J: Prevalence of diabetes among men and women in China. N Engl J Med 2010;362:1090-101.
3. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S: The electrocardiogram in population studies. A classification system. Circulation 1960;21:1160-1175.
4. Relationship of blood pressure, serum cholesterol, smoking habits, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. The Pooling Project Research Group. J ChronicDis 1978;31:201-306.
5. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
6. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
7. Cockcroft DW, Gault HM: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
8. DuBois D, DuBois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-871.
9. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification. Ann Intern Med 2003;139:137-147.
10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-S266.
11. Tsuchiya M, Suzuki E, Egawa K, Nishio Y, Maegawa H, Inoue S, Mitsunami K, Morikawa S, Inubushi T, Kashiwagi A: Stiffness and impaired blood flow in lower-leg arteries are associated with severity of coronary artery calcification among asymptomatic type 2 diabetic patients. Diabetes Care 2004; 27:2409-2415.
12. Lin LX, Chen G, Zou X, Zhao J, Zhu F, Tu M, Xu S, Lin W, Yang S, Zhang Y, Lin M, Chen N, Huang H, Liang J, Li L, Yao J: Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China. Obes Rev 2009;10:420-430.
13. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K: Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 2003;18: 523-530.
14. Dehghan A, Van Hoek M, Sijbrands EJ, Hofman A, Witteman JC: High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008;31:361-362.
15. Chien KL, Chen MF, Hsu HC, Chang WT, Su TC, Lee YT, Hu FB: Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem 2008;54:310-316.
16. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K: Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: Osaka Health Survey. J Hypertens 2001;19:1209-1215.
17. Dehghan A, Van Hoek M, Sijbrands EJG, Hofman A, Witteman JCM: High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008;31:361-362.
18. De Fronzo RA: Lilly Lecture 1987: The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-687.
19. Erbey JR, Silberman C, Lydick E: Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes. Am J Med 2000;109:588-590.
20. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M: Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003;49:1358-1366.
21. Salmela PI, Sotaniemi EA, Niemi M, Maentausta O: Liver function tests in diabetic patients. Diabetes Care 1984;7: 248-254.
22. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, Blomhoff R, Jacobs DR Jr: Gamma-glutamyltransferase and diabetes-a 4 year follow-up study. Diabetologia 2003; 46:359-364.
23. SillanpääM, Aro H: Headache in teenagers: comorbidity and prognosis. Funct Neurol 2000;15(Suppl 3):116-121.
24. Cook NR, Benseñor IM, Lotufo PA, Lee IM, Skerrett PJ, Chown MJ, Ajani UA, Manson JE, Buring JE: Migraine and coronary heart disease in women and men. Headache 2002; 42:715-727.
25. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE: Migraine and risk of cardiovascular disease in women. JAMA 2006;296:283-291. Erratum in: JAMA 2006;296:654, 2006;296:1 p following 291.
26. Knutson KL, Spiegel K, Penev P, Van Cauter E: The metabolic consequences of sleep deprivation. Sleep Med Rev 2007;11:163-178.
27. Ford ES, Zhao G, Li C: Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 2010;55:1310-1317.
28. Pecoraro RE, Reiber GE, Burgess EM: Pathways to diabetic limb amputation: basis for prevention. Diabetes Care 1990; 13:513-521.
29. Singleton JR, Smith AG, Bromberg MB: Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 2001;24;1225-1228.
30. Tesfaye S, Boultion AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P; Toronto Diabetic Neuropathy Expert Group: Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010;33:2285-2293. Erratum in: Diabetes Care 2010;33:2725.
31. AbbottCA,CarringtonAL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, Ryder CH, Torkington R, Van Ross ER, Whalley AM, Widdows P, Williamson S, Boulton AJ; North-West Diabetes Foot Care Study: The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a communitybased patient cohort. Diabet Med 2002;19:377-384.